首页> Clinical oncology (Royal College of Radiologists (Great Britain))> Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer.

Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer.

导出原文传递

翻译打印收藏纠错

第一作者： A,Punjabi

第一单位： Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

作者： A,Punjabi ^[1] ; E,Barrett ^[1] ; A,Cheng ^[1] ; A,Mulla ^[1] ; G,Walls ^[2] ; D,Johnston ^[3] ; J,McAleese ^[3] ; K,Moore ^[4] ; J,Hicks ^[4] ; K,Blyth ^[4] ; M,Denholm ^[5] ; L,Magee ^[5] ; D,Gilligan ^[5] ; S,Silverman ^[6] ; M,Qureshi ^[1] ; H,Clinch ^[7] ; M,Hatton ^[8] ; L,Philipps ^[9] ; S,Brown ^[10] ; M,O'Brien ^[9] ; F,McDonald ^[9] ; C,Faivre-Finn ^[11] ; C,Hiley ^[12] ; M,Evison ^[13]

作者单位： Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. ^[1] Queen's University Belfast, Belfast, UK. ^[2] Northern Ireland Cancer Centre, Belfast, UK. ^[3] NHS Greater Glasgow & Clyde, Glasgow, UK. ^[4] Cambridge University Hospitals NHS Trust, Cambridge, UK. ^[5] University College London Hospital, London, UK. ^[6] The University of Sheffield Medical School, Sheffield, UK. ^[7] Weston Park Hospital, Sheffield, UK. ^[8] Royal Marsden Hospital, London, UK. ^[9] The University of Manchester, Manchester, UK. ^[10] The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK. ^[11] CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK. ^[12] Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: m.evison@nhs.net. ^[13]

关键词 Curative-intent radiotherapy NSCLC lung cancer lymphocyte count neutrophil–lymphocyte ratio